These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37376039)

  • 21. Glucosamine Modified the Surface of pH-Responsive Poly(2-(diethylamino)ethyl Methacrylate) Brushes Grafted on Hollow Mesoporous Silica Nanoparticles as Smart Nanocarrier.
    Beagan A; Lahmadi S; Alghamdi A; Halwani M; Almeataq M; Alhazaa A; Alotaibi K; Alswieleh A
    Polymers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery.
    Yan J; Xu X; Zhou J; Liu C; Zhang L; Wang D; Yang F; Zhang H
    ACS Appl Bio Mater; 2020 Feb; 3(2):1216-1225. PubMed ID: 35019322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Three-in-One" Multifunctional Gatekeeper Gated Mesoporous Silica Nanoparticles for Intracellular pH-Activated Targeted Cancer Therapy.
    Zhang Y; Wang W; Zhang Y; Cheng M; Wu Q; Yuan Z
    ACS Appl Bio Mater; 2018 Sep; 1(3):572-580. PubMed ID: 34996191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theranostic Mesoporous Silica Nanoparticles Loaded With a Curcumin-Naphthoquinone Conjugate for Potential Cancer Intervention.
    Freidus LG; Kumar P; Marimuthu T; Pradeep P; Choonara YE
    Front Mol Biosci; 2021; 8():670792. PubMed ID: 34095225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma.
    Li ZY; Liu Y; Wang XQ; Liu LH; Hu JJ; Luo GF; Chen WH; Rong L; Zhang XZ
    ACS Appl Mater Interfaces; 2013 Aug; 5(16):7995-8001. PubMed ID: 23869943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sugar-conjugated dendritic mesoporous silica nanoparticles as pH-responsive nanocarriers for tumor targeting and controlled release of deferasirox.
    Sodagar Taleghani A; Ebrahimnejad P; Heidarinasab A; Akbarzadeh A
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():358-368. PubMed ID: 30813037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
    Yuan X; Peng S; Lin W; Wang J; Zhang L
    J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
    Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the driving forces of camptothecin interactions on the surface of nanocomposites based on graphene oxide decorated with silica nanoparticles.
    Fonseca LC; de Sousa M; Maia DLS; Visani de Luna L; Alves OL
    Nanoscale Adv; 2020 Mar; 2(3):1290-1300. PubMed ID: 36133053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the stimuli-responsive mesoporous silica nanoparticles as drug delivery system nanotechnology for controlled release and cancer therapy.
    Zhu Y; Bai Y; He J; Qiu X
    3 Biotech; 2023 Aug; 13(8):274. PubMed ID: 37457870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organically surface engineered mesoporous silica nanoparticles control the release of quercetin by pH stimuli.
    Saputra OA; Lestari WA; Kurniansyah V; Lestari WW; Sugiura T; Mukti RR; Martien R; Wibowo FR
    Sci Rep; 2022 Nov; 12(1):20661. PubMed ID: 36450792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-Responsive Drug Delivery and Imaging Study of Hybrid Mesoporous Silica Nanoparticles.
    Li Z; Guo J; Qi G; Zhang M; Hao L
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-Responsive Nanocarriers Based on β-CD-PNIPAM Star Polymer Coated MSN-SS-Fc Composite Particles.
    Guo F; Li G; Ma S; Zhou H; Chen X
    Polymers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox stimuli-responsive hollow mesoporous silica nanocarriers for targeted drug delivery in cancer therapy.
    Tian Y; Guo R; Jiao Y; Sun Y; Shen S; Wang Y; Lu D; Jiang X; Yang W
    Nanoscale Horiz; 2016 Nov; 1(6):480-487. PubMed ID: 32260712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
    Saroj S; Rajput SJ
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-dependent delivery of chlorhexidine from PGA grafted mesoporous silica nanoparticles at resin-dentin interface.
    Akram Z; Aati S; Ngo H; Fawzy A
    J Nanobiotechnology; 2021 Feb; 19(1):43. PubMed ID: 33563280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual stimuli-responsive polyphosphazene-based molecular gates for controlled drug delivery in lung cancer cells.
    Salinas Y; Kneidinger M; Fornaguera C; Borrós S; Brüggemann O; Teasdale I
    RSC Adv; 2020 Jul; 10(46):27305-27314. PubMed ID: 35516962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.